Table 1.

Baseline demographics and disease characteristics

	Saxagliptin*	Control*
N	21	21
Age (years), mean ± SD	58.3 ± 5.7	56.4 ± 8.5
Female, n (%)	11 (52%)	7 (33%)
Race, n (%)
African American	15 (71%)	13 (62%)
White	5 (24%)	6 (29%)
Other	1 (5%)	2 (10%)
Weight (lbs), mean ± SD	202.7 ± 24.5	202.3 ± 38.7
BMI (kg/m2), mean ± SD	32.3 ± 4.2	31.5 ± 4.8
Duration of diabetes (years), mean ± SD	3.7 ± 2.4	3.5 ± 1.8
HbA1C mean ± SD	7.0 ± 0.8	6.6 ± 0.5
Fasting glucose (mg/dL), mean ± SD	127.4 ± 35.9	114.8 ± 25.0
eGFR (mL/min/1.73), mean ± SD	98.9 ± 14.5	93.7 ± 16.7

* No significant differences were observed